Obesity and Cardiovascular Disease – J1I-MC-GZBM

A Randomized, Double-Blind, Phase 3 Study to Investigate the Efficacy and Safety of LY3437943 Once Weekly Compared to Placebo in Participants with Severe Obesity and Established Cardiovascular Disease (TRIUMPH-3)

Register Today!

Trial Information

Start DateJuly 2023
End DateTBD
Trial Duration~ 2years
Number of Visits30
Lead CRCCaitlyn Van Zon
StatusIn Start-up

For additional information
on this trial contact: